Genetic dominance governs the evolution and spread of mobile genetic elements in bacteria by Rodríguez-Beltrán, Jerónimo et al.
Genetic dominance governs the evolution and spread
of mobile genetic elements in bacteria
Jerónimo Rodríguez-Beltrána,b,1, Vidar Sørumc, Macarena Toll-Rierad, Carmen de la Vegaa, Rafael Peña-Millere,
and Álvaro San Millána,b,1
aDepartment of Microbiology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034, Madrid, Spain;
bSpanish Consortium for Research on Epidemiology and Public Health (CIBERESP), 28029, Madrid, Spain cDepartment of Pharmacy, The Arctic University of
Norway, 9037, Tromsø, Norway; dDepartment of Evolutionary Biology and Environmental Studies, University of Zurich, 8057, Zurich, Switzerland;
and eCenter for Genomic Sciences, Universidad Nacional Autonóma de México, 62210, Cuernavaca, Mexico
Edited by Bruce R. Levin, Emory University, Atlanta, GA, and approved May 26, 2020 (received for review January 22, 2020)
Mobile genetic elements (MGEs), such as plasmids, promote
bacterial evolution through horizontal gene transfer (HGT). How-
ever, the rules governing the repertoire of traits encoded on MGEs
remain unclear. In this study, we uncovered the central role of
genetic dominance shaping genetic cargo in MGEs, using antibiotic
resistance as a model system. MGEs are typically present in more
than one copy per host bacterium, and as a consequence, genetic
dominance favors the fixation of dominant mutations over re-
cessive ones. In addition, genetic dominance also determines the
phenotypic effects of horizontally acquired MGE-encoded genes,
silencing recessive alleles if the recipient bacterium already carries
a wild-type copy of the gene. The combination of these two ef-
fects governs the catalog of genes encoded on MGEs. Our results
help to understand how MGEs evolve and spread, uncovering the
neglected influence of genetic dominance on bacterial evolution.
Moreover, our findings offer a framework to forecast the spread
and evolvability of MGE-encoded genes, which encode traits of
key human interest, such as virulence or antibiotic resistance.
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Horizontal gene transfer (HGT) between bacteria is largelymediated by specialized mobile genetic elements (MGEs),
such as plasmids and bacteriophages, which provide an impor-
tant source of genetic diversity and play a fundamental role in
bacterial ecology and evolution (1). The repertoire of accessory
genes encoded on MGEs and their ability to be phenotypically
expressed in different genetic backgrounds are key aspects of
MGE-mediated evolution (2–5). There are several factors known
to impact the fate of horizontally transferred genes in bacteria,
such as the level of gene expression, the degree of protein con-
nectivity, or the biochemical properties of proteins, but the
specific parameters that shape the repertoire of genes encoded
on MGEs remain largely unknown (6–9).
Genetic dominance is the relationship between alleles of the
same gene in which one allele (dominant) masks the phenotypic
contribution of a second allele (recessive). In diploid or poly-
ploid organisms, the evolution of new traits encoded by recessive
mutations is therefore constricted because the presence of a
dominant allele will always block the phenotypic contribution of
the recessive allele [an effect known as Haldane’s sieve (10, 11)].
Most bacteria of human interest carry a single copy of their
chromosome. In haploid organisms like these, new alleles are
able to produce a phenotype regardless of the degree of genetic
dominance of the underlying mutations. Therefore, the role of
genetic dominance in bacterial evolution has generally been
overlooked. However, the bacterial genome consists of more
than the single chromosome; a myriad of MGEs populate bac-
terial cells. Many MGEs, including plasmids and filamentous
phages, replicate independently of the bacterial chromosome
and are generally present at more than one copy per cell, with
copy number ranging from a handful to several hundred (12, 13).
Extrachromosomal MGEs thus produce an island of local poly-
ploidy in the bacterial genome (14, 15). Moreover, HGT in
bacteria mostly occurs between close relatives (16, 17), and genes
encoded on mobile elements can therefore create allelic re-
dundancy with chromosomal genes. In light of these evidences,
genetic dominance should strongly affect both the emergence of
new mutations in MGE-encoded genes and the phenotypic ef-
fects of horizontally transferred alleles.
Results and Discussion
Genetic Dominance Shapes the Emergence of Mutations in MGE-Encoded
Genes. To test whether genetic dominance determines the emer-
gence of mutations in MGE-encoded genes, we used a two-gene
synthetic system conceptually similar to the one that F. Jacob and
J. Monod used to investigate the regulation of the Lac operon (18).
This construct consists of a cI gene, encoding the bacteriophage λ
CI repressor, in control of the expression of a contiguous tetA gene,
which encodes a tetracycline efflux pump (ref. 19 and Fig. 1A). This
system provides tetracycline resistance when tetA transcription is
derepressed. Derepression can be achieved through mutations that
either inactivate the cI gene or disrupt the CI binding site upstream
of tetA (Fig. 1A). The repressor gene provides a large target (714
bp), but mutations inactivating cI should be recessive since in trans
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copies of wild-type CI will still be able to repress tetA. In contrast,
the CI binding site is a short target (166 bp), but mutations in this
region are likely to be dominant because they will lead to non-
repressible, constitutive TetA production.
We produced two otherwise isogenic Escherichia coli MG1655
clones carrying the cI-tetA system either as a single chromosomal
copy (monocopy treatment) or also present on a pBAD plasmid
with ∼20 copies per cell (pCT, multicopy treatment). To maintain
an identical genetic background between the clones, we included an
empty pBAD plasmid in the monocopy treatment (Fig. 1B). We
next calculated the tetracycline resistance phenotypic mutation rate,
defined as the rate at which mutations able to produce a tetracycline
resistant phenotype emerge. Results revealed a 4.84-fold lower
phenotypic mutation rate in the multicopy treatment, despite the
higher cI-tetA copy number (likelihood ratio test statistic 55.0, P <
10−12; Fig. 1C). As the underlying mutation rate is equal for both
clones (i.e., both clones produce mutations at the same rate; like-
lihood ratio test statistic 0.02, P ∼ 1; Fig. 1C), we reasoned that the
observed difference in the emergence of tetracycline-resistant mu-
tants should be due to the different phenotypic effects of dominant
and recessive mutations in each treatment.
To test this possibility, we first analyzed the mutations in the
cI-tetA system and confirmed that they were located in different
regions in each treatment (Wilcoxon signed-rank test, W = 313,
P = 10−06; Fig. 1D and Dataset S1). Most mutants isolated from
the monocopy treatment carried mutations in the cI gene,
whereas multicopy treatment mutations commonly targeted the
intergenic region between cI and tetA genes (Fig. 1D and Dataset
S1). Next, we measured the level of dominance of a random
subset of these mutations. To this end, we determined tetracycline
resistance level (measured as the antibiotic concentration that in-
hibits 90% of growth [IC90]) for clones carrying only the mutant
allele (homozygous mutant), equal number of mutant and wild-type
alleles (heterozygous), and only wild-type alleles (homozygous wild
type; see a scheme of the experimental design in SI Appendix, Fig.
S1). We reasoned that in heterozygous clones, wild-type copies of
the cI-tetA system would mask the resistance level conferred by
recessive mutations but not by dominant mutations. Results showed
that the resistance level of heterozygous clones is lower than that of
the homozygous mutant clones for mutations isolated in the
monocopy treatment but not in the multicopy treatment (paired
Student’s t test t = 6.96, df = 39, P = 2.5 × 10−8 and t = −0.85, df =
39, P = 0.398 for monocopy and multicopy treatments, respectively;
Fig. 1E and Dataset S2). Finally, we used tetracycline resistance
data to calculate the coefficient of dominance (h) of the mutations
under study. h represents the relative resistance level of heterozy-
gous clones compared to homozygous wild-type and mutant clones
and ranges from 0 (completely recessive mutation) to 1 (completely
dominant) (11). As predicted, mutations recovered from the
monocopy treatment were mostly recessive, showing low or in-
termediate h values, while mutations from the multicopy treatment
showed high levels of dominance (ANOVA effect of treatment; F =
70.02, df = 1, P∼ 3 × 10−5; Fig. 1F).
The Interplay between Genetic Dominance and Gene Copy Number
Determines the Emergence of Antibiotic Resistance Mutations. Our
results indicate that genetic dominance determines the rate at





Fig. 1. Genetic dominance and gene copy number modulate phenotypic mutation rates. (A) The cI-tetA system. Under normal circumstances, transcription
from the lambda promoter pM drives the production of the phage repressor CI (red protein) which binds the operator boxes (O1 and O2) located upstream the
tetA gene, thus blocking its expression. (B) Schematic representation of plasmids pBAD, pCT, and the experimental model (note the isogenic nature of the
clones apart from the dosage of cI-tetA). (C) Tetracycline and rifampicin resistance phenotypic mutation rates in the different clones. Error bars represent 84%
confidence intervals. The asterisk denotes statistical significance; n.s., nonsignificant. (D) Location and type of tetracycline resistance mutations in the
monocopy (upper part) and multicopy (lower part) treatments. Blue shading denotes the cI coding region, and red shading denotes the CI binding site plus
the cI-tetA intergenic region. (E) Tetracycline resistance level of the different clones constructed to measure the coefficient of dominance of tetracycline
resistance mutations detailed in D. The tetracycline inhibitory concentration 90 (IC90, in mg/L) of the homozygous mutant clones (Mut) and heterozygous
mutant clones (HT) are represented by boxes. The line inside the box marks the median. The upper and lower hinges correspond to the 25th and 75th
percentiles, and whiskers extend to 1.5 times the interquartile range. Resistance level of the homozygous wild-type clone is indicated by a horizontal gray line
for reference. The letters in the panels correspond to the mutations indicated in D. (F) Coefficient of dominance (h) of 10 mutations described in C and D. Bars
represent the median of eight biological replicates; error bars represent the interquartile range.





















gene dosage provided by MGEs improves the chances of a ben-
eficial mutation being acquired but simultaneously masks the
phenotypic contribution of the newly acquired allele if it is re-
cessive. To study the general effect of this interplay on the evo-
lution of MGE-encoded genes, we developed a computational
model based on the classic fluctuation assay (ref. 20 and Fig. 2A
and SI Appendix, Figs. S2 and S3). This model allows us to sim-
ulate the acquisition and segregation of mutations located in an
extrachromosomal MGE, in this case a plasmid, with a given copy
number. With this information, we can explore the frequency of
antibiotic resistant mutants in the bacterial population at any time
point; this frequency will depend on the distribution of mutated
and wild-type alleles in each individual cell and on the coefficient
of dominance of those mutations (SI Appendix, Fig. S3). The
simulations showed that the frequency of phenotypic mutants in-
creases with plasmid copy number for mutations of high domi-
nance but decreases for mutations of low dominance (Fig. 2A).
The results of the simulation prompted us to test our hypothesis
in a more realistic and meaningful experimental system. To study
the effect of genetic dominance and gene copy number on the
emergence of phenotypic mutants, we used bacterial housekeep-
ing essential genes known to confer antibiotic resistance through
mutations. The genes studied were gyrA (DNA gyrase subunit A),
rpsL (30S ribosomal protein S12), and folA (dihydrofolate re-
ductase). Mutations in these genes, which are present as single
copies in the chromosome, confer resistance to quinolone, ami-
noglycoside, and trimethoprim antibiotics (21, 22).
We expected resistance mutations in gyrA and rpsL to be re-
cessive and resistance mutations in folA to be dominant. The
recessive nature of mutations in gyrA and rpsL can be explained
by the toxic effect produced by the combination of antibiotic and
wild-type alleles. In the case of gyrA, when the quinolone anti-
biotic binds to the gyrase, double-strand DNA breaks occur,
leading to cell death (23). In the case of streptomycin and rpsL,
binding of the antibiotic to RpsL in the ribosome leads to mis-
translation events producing a toxic effect in the cell (24).
Therefore, even if resistance mutations reduce or avoid the
binding of the antibiotic to the mutated target, the presence of
wild-type enzymes in the cell will still produce a toxic effect,
explaining the predicted recessive nature of mutations in these
two genes (25, 26).
FolA is a key enzyme in folate metabolism. Specifically, it
catalyzes the reduction of dihydrofolate to tetrahydrofolate.
Trimethoprim binds to wild-type FolA and inhibits its activity,
blocking folate metabolism and producing a bacteriostatic effect.
Mutations in FolA confer trimethoprim resistance through re-
duction of FolA binding affinity to the drug and/or by increasing
FolA activity [both by increasing expression or by specific mu-
tations that increase enzymatic activity (21, 27)]. In this case, the
binding of trimethoprim to FolA does not produce a toxic effect
per se. Therefore, in the presence of trimethoprim a cell carrying
an antibiotic resistant version of the enzyme will be able to re-
duce dihydrofolate and grow even if there are wild-type copies of
FolA, explaining the predicted dominance of these mutations.
For each gene under study, we produced two otherwise iso-
genic E. coli MG1655 clones with either one copy of the gene
(chromosomal) or multiple copies (chromosomal + plasmid = 20
copies; SI Appendix, Fig. S4). We calculated phenotypic mutation
rates for each clone using fluctuation assays with the appropriate
antibiotics and sequenced the target genes in the resistant clones
BA
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Fig. 2. Interplay between genetic dominance and gene copy number. (A) Results of simulations analyzing the effect of plasmid copy number and genetic
dominance of a mutation on the emergence of phenotypic mutants. The chart shows fold changes in phenotypic mutation rate for a plasmid-carried gene at
different copy numbers compared with a chromosomal copy of the same gene (black line). (Inset) The comparison of experimental results obtained for gyrA
and folA (presented in B and C) with the prediction for a plasmid of 20 copies. (B) Fold change of antibiotic resistance phenotypic mutation rates in E. coli,
comparing multicopy and monocopy treatments for gyrA, rpsL, and folA. Error bars indicate 84% confidence intervals. Note that result for rpsL is an upper bound
due to the absence of phenotypic mutants in the multicopy treatment (Materials and Methods). (C) Antibiotic resistance phenotypes of the clones constructed to
measure the coefficient of dominance of gyrAD87N (nalidixic acid), rpsLK43T (streptomycin), and folAL28R (trimethoprim) resistance mutations. The inhibitory
concentration 90 (IC90, in mg/L) of the homozygous mutant clones (Mut), heterozygous mutant clones (HT), and homozygous wild-type clones (WT) are repre-
sented by boxes. The line inside the box marks the median. The upper and lower hinges correspond to the 25th and 75th percentiles, and whiskers extend to
1.5 times the interquartile range. Asterisks denote statistically significant differences (Student’s t test P < 0.0002 in all cases); n.s., nonsignificant. (D) Coefficient of
dominance of gyrAD87N, rpsLK43T, and folAL28R. Bars represent the median of eight biological replicates; error bars represent the interquartile range.



























to confirm the presence of mutations (Fig. 2B and Dataset S1). As
expected, the frequency of gyrA and rpsLmutants in the multicopy
treatment was lower than in the monocopy treatment (likelihood
ratio test statistic 49.48, P < 10−12). Conversely, the mutation rate
for folA in the multicopy treatment increased threefold (likelihood
ratio test statistic 5.38, P = 0.02).
To confirm that the genetic dominance is responsible for these
results, we experimentally determined the level of resistance of
homozygous mutant, homozygous wild-type and heterozygous
clones of a common mutation for each gene. We found that for
folAL28R mutation the resistance level of heterozygous clones is
similar to that of the homozygous mutant clones, while for
gyrAD87N and rpsLK43T mutations the resistance level of hetero-
zygous clones is similar to that of the homozygous wild-type
clones (Fig. 2C). We calculated the coefficient of dominance
and confirmed that mutations in gyrAD87N (h = 0.043) and
rpsLK43T (h = 0) were recessive, whereas mutation in folAL28R
(h = 0.748) was dominant (Fig. 2D).
Genetic Dominance Limits the Spread of Antibiotic Resistance.While
our results showed that genetic dominance shapes the emer-
gence of mutations in MGE-encoded genes, they leave open the
question of how genetic dominance affects the phenotypic effects
of horizontally transferred genes in recipient bacteria. HGT in
bacteria preferentially occurs between close relatives, which
leads to the transfer of redundant genes between cells (16, 17).
We hypothesized that phenotypic expression of recessive alleles
encoded on MGEs will be masked if the recipient bacterium
possesses a chromosomal copy of the dominant allele, effectively
hindering transfer of the recessive allele. We tested this hy-
pothesis in an experimental assay of bacterial conjugation, using
the low-copy number mobilizable plasmid pSEVA121 (28). The
plasmid was modified by independent insertion of mutant,
resistance-conferring gyrAD87N (recessive) and folAL28R (domi-
nant) alleles and their wild-type counterparts (SI Appendix, Fig.
S5). We transferred these plasmids from E. coli β3914 to E. coli
MG1655 (Fig. 3A). After conjugation, resistance conferred by
folAL28R was readily expressed in the recipient cells, whereas
resistance conferred by gyrAD87N was masked by the resident
wild-type allele, preventing phenotypic expression of resistance
in transconjugants (Fig. 3A). A simple model of the general ef-
fect of genetic dominance on the phenotypic outcome of trans-
ferred housekeeping genes predicted that the presence of a
dominant allele in the recipient cell would reduce phenotypic
expression of recessive alleles over a wide range of plasmid copy
numbers (Fig. 3B). Crucially, this effect will be particularly
marked for conjugative plasmids, due to their low copy number
in the host cell (typically ranging from 1 to 5).
Genetic Dominance Shapes the Repertoire of Antibiotic Resistance
Genes on MGE. Our results strongly suggest that genetic domi-
nance may be an important factor determining the frequency of
antibiotic resistance alleles of housekeeping genes in MGE. This
is of critical relevance as many antibiotic resistance genes of
clinical concern were originally resistant variants of chromo-
somal genes that were mobilized by MGE (29, 30). To investigate
this further, we analyzed the Comprehensive Antibiotic Resistance
Database (CARD), which includes detailed information about
antibiotic resistance genes from thousands of bacterial chromo-
somes and plasmids (31). To extend our analysis to other MGEs,
we also examined databases for information on integrative and
conjugative elements (ICEs) and prophages. We predicted that
housekeeping alleles conferring antibiotic resistance and con-
tained in MGEs would be more frequently dominant than re-
cessive. We investigated the genes in our experimental system plus
two additional housekeeping genes that, according to results from
previous works, should confer antibiotic resistance through dom-
inant (folP, dihydropteroate synthase, sulfonamide resistance) and
recessive (rpoB, RNA polymerase subunit beta, rifampicin re-
sistance) mutations (refs. 32–34 and SI Appendix, SI Text). Results
confirmed that mobile resistance-conferring alleles of folA and
folP (dominant) were ubiquitous in naturally occurring MGEs,
whereas resistance alleles of rpoB, gyrA, and rpsL (recessive) were
almost never present in MGEs (Fig. 4A). We note, however, that
alternative explanations to genetic dominance, such as protein
connectivity or the fitness effects produced by these genes in re-
cipient bacteria (SI Appendix, Figs. S6 and S7), could also con-
tribute to explain the observed bias in gene distribution. As a
matter of fact, RpoB and RpsL show a high degree of protein
connectivity, whereas GyrA is involved in a similar number of
protein–protein interactions to FolA and FolP (SI Appendix, Fig.
S7). Additionally, effects typically associated with increased ploidy
levels such as changes in gene expression and pleiotropic
protein–protein interactions between chromosomal and mobile
genes can also play a significant role in the observed results (35).
To obtain a more general view of the effect of genetic domi-
nance on the distribution of resistance genes on MGE/chromo-
somes, we further extended our analysis to all possible antibiotic
Fig. 3. Genetic dominance limits the phenotypic contribution of horizontally transferred recessive alleles. (A) Pictures of a representative replicate of the
conjugation assays. Overnight cultures of spots inoculated from 10-fold dilutions of conjugation mixes (100 to 10−4, from left to right) on plates selecting for
transconjugants. Selection on carbenicillin reveals the actual number of transconjugants; selection on carbenicillin plus nalidixic acid or trimethoprim reveals the
number of transconjugants carrying gyrA and folA alleles and expressing the resistant phenotype. (B) Antibiotic resistance level conferred by a plasmid-encoded
resistance allele in the recipient bacterium (when a wild-type copy of the gene is present in the chromosome), assuming phenotypic resistance as the product of
plasmid copy number and the coefficient of dominance of the allele. Experimental data are presented for gyrAD87N and folAL28R in plasmid pSEVA121.





















resistance genes according to their Antibiotic Resistance On-
tology (ARO, grouped by “determinant of antibiotic resistance,”
data obtained from CARD). We calculated the proportion of
resistance genes belonging to each of the categories in MGE and
chromosomes. Notably, efflux pumps represent more than 60%
of all resistance determinants located in chromosomes, probably
as a consequence of their role in bacterial physiology beyond
antimicrobial resistance (36). As the extreme overrepresentation
of pumps in chromosomes might bias our results, we performed
the analyses including and excluding efflux pumps and obtained
qualitatively similar results (see below and SI Appendix, Fig. S8).
Although the evolutionary forces driving this divergence are
likely to be complex (4–7), we predicted that categories enriched
in the few dominant resistance alleles of chromosomal genes or
in those genes with no resident counterpart in the host bacterium
(xenogeneic genes) should be overrepresented in MGE com-
pared to chromosomes, whereas the opposite should be true for
categories enriched in recessive alleles. We compared the pro-
portion of resistance determinants in each category for MGE
and chromosomes under the null hypothesis of equal propor-
tions. In agreement with our predictions, we found that genes
belonging to the antibiotic inactivation, target protection, and
target replacement categories were consistently overrepresented
in MGE (Bonferroni corrected Fisher’s exact test P < 0.003 in all
cases; Fig. 4B and SI Appendix, Fig. S8). These categories include
mostly dominant alleles, because they are composed of genes
encoding enzymes of xenogeneic origin that are known to confer
resistance in virtually all gram-positive and gram-negative bacteria
(e.g., antibiotic inactivating β-lactamases or target protection Qnr
proteins) (37, 38) or of dominant alleles of housekeeping genes
that replace the sensitive antibiotic target such as folP (sul) and
folA (dfr). The molecular by-pass category was also significantly
overrepresented in MGE when accounting for efflux pumps but
underrepresented when efflux pumps were removed from the
analysis (Bonferroni corrected Fisher’s exact test P < 10-7 in both
cases). Despite this discrepancy, most MGE-encoded genes from
this category are dominant vancomycin-resistant van alleles, which
are able to confer resistance in the presence of the susceptible
chromosomal cell wall synthesis pathway (39).
On the other hand, genes belonging to the reduced perme-
ability to antibiotic category are underrepresented in MGEs
(Fisher’s exact test; Bonferroni corrected P < 10−15; Fig. 4B and
SI Appendix, Fig. S8). This category includes mainly house-
keeping porin genes carrying loss of function mutations, which
are recessive alleles, as the presence of wild-type alleles will
render the cell sensitive. A prediction that stems from this result
is that loss of function mutations should be scarce in MGE
compared to chromosomes. This might include mutations in
efflux pumps regulators and is certainly the case for mutations in
AmpC β-lactamases regulators (ampR and ampD), which are
common in chromosomal ampC systems but extremely infrequent
on plasmid-encoded ones (40, 41).
In light of these results, we propose that genetic dominance
contributes to explain the commonly observed divergence be-
tween chromosomal and MGE-mediated antibiotic resistance
genes (42, 43). Our results suggest that chromosomal singletons
are free to explore their mutational landscape in a host bacte-
rium, but only dominant alleles are able to provide a selectable
phenotype, reach fixation, and spread successfully on MGEs.
Conclusion
In this work we demonstrate that genetic dominance strongly
influences evolution through MGEs in bacteria, revealing an
extra layer of complexity in the forces governing HGT. The im-
pact of genetic dominance on MGEs is twofold, affecting both 1)
the emergence of new mutations in MGE-encoded genes and 2)
the phenotypic effects of horizontally transferred genes. The first
effect is driven by the polyploid nature of extrachromosomal
MGEs, which induces the filtering of recessive mutations through
Haldane’s sieve. However, elevated gene copy number is not an
exclusive property of MGEs and can arise physiologically in haploid
bacteria in multiple circumstances. For example, gene copy number
is increased by gene duplication events and by transient polyploidy
during fast bacterial growth (44, 45), suggesting a potential broader
influence of genetic dominance on bacterial evolution. The second
effect is determined by the dominance relationships that emerge
when a new allele arrives in a bacterium that already carries a copy
of that gene. Given that HGT in bacteria is strongly favored be-
tween close relatives (16, 17), genetic redundancy of this type must
be extremely common, underlining the importance of genetic
dominance in determining if a given allele is likely to spread hori-
zontally. Together, our findings shed light on the forces that shape
MGE-mediated evolution and offer a framework to forecast which
genes will spread on MGE.
Materials and Methods
Strains, Plasmids, and Media. All of the strains and plasmids used in this study
are detailed in Dataset S3. Experiments were performed using Muller Hinton
II agar or cation adjusted broth (Becton Dickinson) unless specified. Antibiotics
were supplied by Sigma-Aldrich and were used at the following concentra-
tions: carbenicillin 100 μg/mL, chloramphenicol 30 μg/mL, nalidixic acid 30 μg/
mL, streptomycin 100 μg/mL, rifampicin 100 μg/mL, trimethoprim 2 μg/mL and
16 μg/mL, and tetracycline 15 μg/mL. Cultures were routinely grown at 37 °C
with shaking (225 rpm). Plasmids were extracted using a commercial miniprep
kit (Macherey-Nagel) and were transformed into TSS competent cells (46).
Cloning and Site-Directed Mutagenesis. The gyrA, rpsL, and folA wild-type
alleles were PCR amplified using HS Taq Mix (PCR Biosystems) polymerase,
using the primers listed in Dataset S4 and MG1655 chromosomal DNA as
A B
Fig. 4. Genetic dominance shapes the bacterial mobilome. (A) Prevalence of antibiotic resistance-conferring alleles of rpoB, rpsL, gyrA, folA, and folP (in-
dicated with an asterisk) in chromosomes and MGEs across bacteria. (B) Proportion of antibiotic resistance genes belonging to each resistance category on
MGE (n = 6,053) and chromosomes (n = 26,147; see also SI Appendix, Fig. S8).



























template. The cI-tetA system was amplified similarly but using IBDS1 as a
template (19). Purified PCRs were subsequently cloned into the pBAD TOPO
TA Expression kit (Thermo-Fisher) following manufacturer instructions. We
selected clones in which the insert was cloned in the opposite direction from
that of the PBAD promoter to ensure that expression is driven only from the
cognate promoter. Correct clones were identified by PCR and Sanger se-
quenced to give rise to pBAD-gene and pCT plasmids (Dataset S3).
Site-directed mutagenesis was performed on the pBAD plasmids carrying
wild-type alleles to construct the gyrAD87N, rpsLK43T, and folAL28R mutated
alleles by using the Q5 site-directed mutagenesis kit (New England Biolabs)
and the primers listed in Dataset S4. Correct cloning was assessed by PCR and
Sanger sequencing. Next, we generated pBDSM plasmid variants by Gibson
assembling PCR amplified (Phusion Hot Start II DNA Polymerase, Thermo-
Fisher; see Dataset S4 for primers) mutated and wild-type alleles into the
pBGC backbone (SI Appendix, Fig. S4 and Dataset S3)
Tetracycline resistance mutations in the pCT plasmid isolated in the
fluctuation assays were purified by plasmid extraction and retransformed
into MG1655, selecting in carbenicillin and tetracycline plates to isolate pCT
mutated plasmids from the wild-type plasmids that could be coexisting
under heteroplasmy (14). Isolated pCT plasmids and chromosomal mutants
carrying cI-tetA mutated cassette were PCR amplified (Phusion Hot Start II
DNA Polymerase; Thermo-Fisher) and simultaneously Gibson assembled
(NEBuilder HiFi DNA Assembly kit; New England Biolabs) into the pBAD and
pBGC backbones using the primers listed in Dataset S4 to give rise to pBAD
and pBDSM plasmids carrying mutated alleles of the cI-tetA system (SI Ap-
pendix, Fig. S1 and Dataset S3).
Fluctuation Assays for Mutation Rate Determination. Briefly, independent
cultures containing carbenicillin were inoculated with ∼103 cells and allowed
to grow during 18 h at 37 °C with shaking (225 rpm). The following day,
appropriate aliquots were plated in antibiotic-containing agar plates to se-
lect for spontaneous mutants and in nonselective plates to determine the
number of viable bacteria. After incubation at 37 °C for 24 h (48 h for ri-
fampicin and streptomycin plates), colonies were enumerated. The genes
suspected of carrying mutations were PCR amplified and Sanger sequenced
using mutant colonies coming from independent cultures as template. In
some cases, Sanger reads from the multicopy treatment showed mixed reads
and/or unclear results. In those cases, plasmids from the resistant colonies
were extracted and retransformed into MG1655 competent cells. Trans-
formants were selected on plates containing carbenicillin (selecting for plas-
mids) and carbenicillin plus tetracycline (selecting for plasmids carrying
tetracycline resistance mutations). The following day, transformant colonies
from plates containing carbenicillin plus tetracycline were PCR amplified and
Sanger sequenced. This simple procedure allows us to separate plasmids car-
rying dominant resistance mutations fromwild-type plasmids coexisting within
the same cell under heteroplasmy (14). Phenotypic mutation rates, defined as
the rate at which mutations producing a resistance phenotype emerge, 84%
confidence intervals, and likelihood ratio tests to assess statistical significance
were then calculated using the newton.LD.plating, confint.LD.plating and
LRT.LD.plating functions of the Rsalvador package for R (47). We used 84%
confidence intervals because it has been demonstrated that they convey sta-
tistical significance better than 95% confidence intervals (48).
Monocopy and multicopy strains of gyrA and rpsL presented the same
antibiotic resistance levels, indicating that target overexpression did not
increase the level of resistance for these genes (Dataset S2). However, and as
previously reported (49), folA overexpression led to an eightfold increase in
the trimethoprim resistance level in the multicopy treatment. To perform
the mutation rate assay, we used the lowest antibiotic concentration pos-
sible that inhibits the growth of nonmutant colonies and maximizes the
recovery of mutant cells. These concentrations were 2 and 16 μg/mL for the
monocopy and multicopy treatments, respectively, which correspond to
4 times the IC90 of trimethoprim for each clone. Sequencing of folA PCR
products revealed mutations in all of the colonies tested from the monocopy
treatment but only for ∼10% of the ones from the multicopy treatment. This
result could be due to the lack of fixation of folA mutations, which can be
maintained at a low frequency in heteroplasmy and not be evident in the
chromatogram, or due to the access to different resistance mutations in this
treatment. To solve this problem and recover only folA mutants, we in-
troduced an extra step in the fluctuation assays for the multicopy treatment,
where we restreaked the colonies from 16 to 50 μg/mL trimethoprim plates.
This step allowed us to recover colonies carrying folAmutations only (avoiding
false positives) while at the same time allowing the recovery of colonies car-
rying folA mutations even if the frequency of folA mutated alleles in heter-
oplasmy would have been too low to initially grow on this concentration
during a fluctuation assay (avoiding false negatives) (Dataset S1).
For rpsL, we were not able to recover a single resistant colony in the
fluctuation assays for the multicopy treatment (Dataset S1). Subsequent
analyses revealed that the coefficient of dominance of the most common
rpsL mutation isolated in the chromosome is 0. The complete recessiveness
of rpsL streptomycin resistance mutations explains the absence of resistant
mutants in the multicopy treatment because even if the plasmid-mediated
copy of rpsL mutates and reaches fixation prior to plating, the wild-type
chromosomal copy of the gene masks the resistance phenotype. There-
fore, for phenotypic resistant mutants to appear, both chromosomal and
plasmid copies of the gene should mutate (and reach fixation in the cell),
which is extremely unlikely. In Fig. 2B we present the fold change of
streptomycin resistance phenotypic mutation rate using the mutation rate
calculated for the monocopy treatment and the limit of detection of the
mutation rate for the multicopy treatment. Rifampicin mutation rates were
performed in all cases to confirm that the underlying mutation rate is equal
for all clones used in this study (Fig. 1 and SI Appendix, Fig. S9).
Coefficient of Dominance. The coefficient of dominance (h) of mutations
ranges from 0, completely recessive, to 1, completely dominant. To calculate
h, we developed an experimental system based on two compatible plasmids
of similar copy number (n ∼ 15 to 20) (50, 51), where we cloned the genes of
interest carrying the wild-type or mutant alleles under investigation (SI
Appendix, Fig. S1). We then transformed E. coli MG1655 with the single
plasmids and the combinations of plasmids to produce the two possible
heterozygous clones. To construct the homozygous mutant clones for
rpsLK43T and gyrAD87N, we used the MG1655 background carrying the same
mutation in the chromosomal copy of the gene under study. We then per-
formed antibiotic susceptibility assays to determine the resistance pheno-
types of the different clones (measured as inhibitory concentration 90, IC90).
Using the IC90 values we calculated h with the following formula:
h = IC90aA-IC90AA( )= IC90aa-IC90AA( ),
where IC90AA, IC90aA, and IC90aa are the IC90 of the homozygous wild-type,
heterozygous, and homozygous mutant clones, respectively. Since there are
two different heterozygous clones (SI Appendix, Fig. S1), we calculated h as
the median value of four independent replicates of each heterozygous clone
(n = 8; Dataset S2).
IC90 values were obtained following ref. 52, with some alterations. In
short, strains were streaked from freeze stock onto Mueller Hinton II agar
plates and incubated overnight at 37 °C. Single colonies were picked and
suspended in liquid Mueller Hinton II broth and incubated at 37 °C and 225
rpm. Overnight cultures were diluted 1:10,000 into Mueller Hinton II broth
to a final volume of 200 μL per well in microtiter plates. The wells contained
increasing concentrations of the appropriate antibiotic in 1.5-fold incre-
ments. Plates were incubated at 37 °C for 22 h and 225 rpm. After incubation
we ensured homogenous mixture of bacteria by orbital shaking for 1 min
(548 rpm with 2-mm diameter) before reading of OD600 in a Synergy HTX
(BioTek) plate reader. IC90 is defined as ≥90% inhibition of growth which
was calculated using the formula 1 – [ODdrug/ODcontrol], where the control is
the no-antibiotic treatment. Wells only containing media were used for
background subtraction. Appropriate antibiotic for plasmid maintenance
was included in the media throughout the assay.
Conjugation Assays. We developed an experimental model system to de-
termine the frequencies of conjugation of plasmids pSEVA121-gyrA,
pSEVA121-gyrAD87N, pSEVA121-folA, and pSEVA121-folAL28R between E. coli
strains (SI Appendix, Fig. S5). pSEVA121 is a vector carrying the IncP-type RK2
(also called RP4) replicon, with a trfA replication initiator protein gene plus
the oriV origin of replication and the oriT origin of transfer. pSEVA121
displays, therefore, low copy number in the host cell (circa four copies per
cell) (53), representing a great model system to reproduce the features of a
natural conjugative plasmid. To mobilize pSEVA121 we used strain β3914 as
donor, which is auxothropic for diaminopimelic acid and carries RP4 conju-
gation machinery inserted in the chromosome. As a recipient we used E. coli
MG1655 (Dataset S3).
Precultures of donor and recipient strains were incubated overnight in
2 mL of Mueller Hinton broth with the appropriate antibiotics at 37 °C and
225 rpm. Next day, 1:100 dilution of the overnight cultures in 5 mL of
Mueller Hinton broth were incubated until the culture reached mid-
exponential phase at 37 °C and 225 rpm (2.5 h approximately). Cultures were
then centrifuged for 15 min at 1,500 × g, and the pellets were resuspended
in 200 μL of fresh Mueller Hinton broth; 50 μL of donor and 10 μL of recipient
suspensions were mixed and spotted on Mueller Hinton agar plates.





















The conjugation mix was incubated for 18 h at 37 °C and then suspended
in 2 mL of 0.9% NaCl sterile solution. Dilutions of this suspension were spotted
as 5-μL drops onMueller Hinton agar plates containing antibiotics selecting for
donor, recipient, and transconjugant cells. The total number of trans-
conjugants was determined by selecting on carbenicillin, while the number of
transconjugants expressing the resistance phenotype conferred by gyrA and
folA alleles were selected on carbenicillin plus nalidixic acid or trimethoprim,
respectively. We performed four independent biological replicates of each
conjugation assay, and we show one representative replicate in Fig. 3A.
Growth Curves. Growth curves were performed in a Synergy HTX (BioTek)
plate reader. Briefly, overnight cultures were diluted 1:1,000 in Mueller
Hinton broth supplemented with carbenicillin, and 200 μL of the dilutions
were transferred to a 96-well multiwell plate (Thermo Scientific). Plates were
incubated at 37 °C with strong orbital shaking before reading absorbance at
600 nm every 15 min. Six biological replicates were included per strain.
Bioinformatic Analysis. CARD prevalence data containing an analysis of 82
pathogens with more than 89,000 resistomes and more than 175,000 anti-
microbial resistance allele sequences were obtained from the CARD website
(31) (downloaded on 18 September 2019).
We downloaded all available bacterial ICEs from ICEberg 2.0 database (54),
amounting to a total of 806 ICEs from which 662 were conjugative type IV
secretion system (T4SS)-type ICEs, 111 were chromosome-borne integrative
and mobilizable elements, and 33 were cis-mobilizable elements. A total of
741 perfect and strict hits from 267 ICEs were identified using CARD RGI
(version 4.2.2, parameters used: DNA sequence, perfect and strict hits only,
exclude nudge, high quality/coverage, and we used DIAMOND to align the
CDS against the CARD database).
We downloaded all complete bacterial genomes from NCBI, a total of
13,169 genomes (assembly level: complete, downloaded on 15 February
2019). We used the algorithm phiSpy to identify prophages in the bacterial
chromosomes, and we predicted a total of 30,445 prophages in 7,376 ge-
nomes (55). To study the presence of genes conferring antibiotic resistance
in prophages, we extracted the CDS overlapping with prophages, and we
predicted their resistome using the command line tool CARD RGI as above.
We then used the antibiotic resistance data from prophages, ICEs, plas-
mids, and chromosomes to calculate the prevalence of the following Anti-
biotic Resistance Ontology (ARO) categories: “antibiotic resistant DNA
topoisomerase subunit gyrA” (ARO: 3000273), “antibiotic resistant rpsL” (ARO:
3003419), “sulfonamide resistant dihydropteroate synthase” (ARO: 3000558),
“antibiotic resistant rpoB” (ARO:3003276), and “antibiotic resistant dihy-
drofolate reductase” (ARO:3003425). To test the overrepresentation or un-
derrepresentation of resistance mechanisms in MGEs and chromosomes, we
used the following ARO categories to query our database: “antibiotic target
replacement protein” (ARO:3000381), “antibiotic inactivation enzyme”
(ARO:3000557), “antibiotic target protection protein” (ARO:3000185), “protein
modulating permeability to antibiotic” (ARO:3000270), “protein(s) conferring
antibiotic resistance via molecular bypass” (ARO:3000012), and “efflux pump
complex or subunit conferring antibiotic resistance” (ARO:3000159). We used
the number of genes encoded in MGE and chromosomes to build a 2 × 2 con-
tingency table for each category, in which the first column contains the number
of genes in a given category in MGE and chromosomes and the second column
contains the number of resistance genes that do not belong to that category.
We used two-tailed Fisher’s exact test to test whether there are different pro-
portions of chromosomal versus MGE-encoded antibiotic resistance determinants
in each category and adjusted the resulting P values for multiple comparisons
using Bonferroni’s method.
Connectivity data for all protein families were downloaded from the
STRING (Search Tool for Retrieval of Interacting Genes/Proteins) database
(56), and the number of high-confidence interactions (>700 STRING confi-
dence) was determined for each protein family.
Stochastic Model. We assume that plasmids replicate randomly throughout
the cell cycle until reaching an upper limit determined by the plasmid copy
number control mechanism. Therefore, the probability of plasmid replication
can be modeled as 1 − ni(t)=N, where ni(t) represents the number of copies of
a plasmid of type i at time t and N is the maximum number of plasmids. We
explicitly consider random mutations occurring during replication events, so if
μ> 0 denotes the probability of a mutation occurring in a plasmid, the per-cell
mutation rate is μ ·n. Stochastic simulations of mutation and replication dy-
namics were performed using a Gillespie algorithm implemented in MATLAB
with propensities determined from the distribution of plasmid copies of each
allele carried by the cell (code can be downloaded from GitHub; https://github.
com/ccg-esb/dominatrix) (SI Appendix, Fig. S2).
We also consider that plasmids segregate randomly during cell division.
The probability that each plasmid is inherited to one of the daughter cells is a
random process that follows a binomial distribution. By implementing an
agent-based extension of the replication–mutation model coupled with the
segregation dynamics, we simulated the intracellular plasmid dynamics of
individual cells in an exponentially growing population (SI Appendix, Fig.
S3). The frequency of phenotypic mutants observed in the population at the
end of the numerical experiment was estimated from the fraction of mu-
tated/wild-type alleles in each individual cell and the coefficient of domi-
nance of those mutations (h). The results presented in this study were
obtained after 106 simulation runs in a range of plasmid copy numbers
(Fig. 2A). Finally, we used Rsalvador package (47) to estimate from this
synthetic data the fold change in phenotypic mutation rate with respect to
chromosomally encoded genes.
Statistical Analyses. All statistical tests, analysis, and plots were performed
using R (v. 3.4.2).
Data Availability. All data generated during this study are included in this
published article (and SI Appendix).
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